Skip to main navigation Skip to search Skip to main content

SeaStar Medical Announces Details of the Selective Cytopheretic Device Pivotal Study in Critically ill Adults with Acute Kidney Injury

  • Kevin Chung

Press/Media

Period16 Feb 2023

Media coverage

1

Media coverage